Tenidap--a new antiarthritic agent.
Tenidap sodium is a novel cytokine inhibitor. Early studies in RA suggest a disease modifying profile as well as providing symptomatic relief. The drug is also effective in OA at a significantly lower dose. The results of clinical trials in RA and OA, which address efficacy and safety, are awaited with interest.
University of New South Wales, St. Vincent's Hospital, Darlinghurst, Australia.
P M
PM
Brooks
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D000078183:Oxindoles
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D000078183:Oxindoles; C062866:tenidap